Nephrology Healthcare Market Scenario of India


Chronic kidney disease (CKD) is an important, chronic, non-communicable disease epidemic that affects the world, including India

Global Burden of Disease 2015 ranks chronic kidney disease as the eighth leading cause of death in India.

Considering the above facts Hospaccx team started working the mapping of market trends and dynamic. This is macroficial study of diabetic market if you want to get into more detail you can contact [email protected]


  • 10% of the population worldwide is affected by chronic kidney disease (CKD), and millions die each year because they do not have access to affordable treatment.
  • More than 80% of all patients who receive treatment for kidney failure are in affluent countries with universal access to health care and large elderly populations.
  • In the US, treatment of chronic kidney disease is likely to exceed $48 billion per year. Treatment for kidney failure consumes 6.7% of the total Medicare budget to care for less than 1% of the covered population.
  • In China, the economy will lose US$558 billion over the next decade due to effects on death and disability attributable to heart disease and kidney disease.
  • In England, according to a recent report published by NHS Kidney Care, chronic kidney disease costs more than breast, lung, colon and skin cancer combined.
  • In Australia, treatment for all current and new cases of kidney failure through 2020 will cost an estimated $12 billion.


  • 1827 – Richard Bright initially recognized of kidney disease as independent from other medical conditions.
  • 1875 – The study of kidney disease was furthered by William Howship Dickinson’s description of acute nephritis.
  • 1870s – Frederick Akbar Mahomed’s discovery of the link between kidney disease and hypertension.
  • 1896 – Mahomed’s original sphygmograph, created when he was a medical student, by Scipione Riva-Rocci, of Italy, with the use of a cuff to encircle the arm.
  • 1900s – Investigators such as Homer Smith revealed the underlying physiology of the kidney.
  • 1945 – Therapy in the field of nephrology was further advanced with the first successful use of hemodialysis by Willem Kolff.
  • 1963 – One of the first successful case series describing the use of immunosuppression was reported in the New England Journal of Medicine by Murray and colleagues.
  • 1970s – Leading to the new and effective immunosuppressive agents such as cyclosporin A, tacrolimus, mycophenolate mofetil, sirolimus, and monoclonal antibodies.


1. The Home Dialysis Evolution

Newer technology by Mr. Jeffrey Hymes (US), makes it even easier for patients to dialyze at home continues to evolve at Fresenius Medical Care. There is increasing recognition of the benefits of home dialysis. Advantages include convenience, independence, privacy and a sense of autonomy for the patient.

2. Artificial Kidney

The device that can be implanted in the abdomen and will be powered by the heart is designed to filter the blood and perform other kidney functions, including production of hormones, and help assist in blood pressure control. The fist-sized artificial kidney hits the market, possibly by the end of the decade.

The device being engineered in the US will go through a series of safety and efficacy trials on hundreds of patients in that country before it is approved by the FDA, University of California San Francisco researcher Dr Shuvo Roy, co-inventor of the device.


  • In India, diabetes and hypertension today account for 40–60% cases of CKD.
  • As per recent Indian Council of Medical Research data, prevalence of diabetes in Indian adult population has risen to 7.1% and in urban population the prevalence is as high as 28%.
  • The reported prevalence of hypertension in the adult population today is 17% (14.8% from rural and 21.4% from urban belt).
  • With rising prevalence of these diseases in India, prevalence of CKD is expected to rise.


  • In India, the cost varies from US$20 to 60, depending on the type of facility.
  • 1% of patients in public hospitals are spending over 100% of their monthly income on dialysis compared to 78.9% of patients in private care.


The Pradhan Mantri National Dialysis Programme was rolled out in 2016 as part of the National Health Mission (NHM) for provision of free dialysis services to the poor. The Guidelines for Pradhan Mantri National Dialysis Programme envisage provision of dialysis services under NHM in PPP (Public Private Partnership) mode.

Currently, under NHM 100 % of the service procedure fees for patients from below poverty line (BPL) economic group is covered. However, non BPL patients would have the benefit of accessing the services close to the community at the district hospitals at same rates as paid by the Government for the BPL patient.

While the exits health schemes such as Rashtriya Swasthya Bima Yojana (RSBY) funded by Govt. of India which cover hemodialysis procedure, it is evident that due to high cost and recurring sessions required over the life time, the total cost for providing dialysis cannot be adequately covered. However, for BPL families registered under RSBY, the cost of dialysis care shall be catered through RSBY funding up to its maximum coverage. The additional resources required would be provided to the state under the National Health Mission. 


  • The global nephrology and urology devices market size is expected to reach USD 31.3 billion by 2024 exhibiting a 7.1%.
  • The global Chronic Kidney Disease (CKD) Drugs market was valued at US$ 12.4 Bnin 2016, and is expected to reach US$ 17.4 Bn by 2025, expanding at a CAGR of 3.9% from 2017 to 2025.
  • In the 2015 Global Burden of Disease Study, kidney disease was the 12th most common cause of death, accounting for 1.1 million deaths worldwide. Overall CKD mortality has increased by 31.7% over the last 10 years, making it one of the fastest rising major causes of death, alongside diabetes and dementia. In the same study, CKD ranked as the 17th leading cause of global years lost of life, an 18.4% increase since 2005, and the third largest increase of any major cause of death.


  • Incidence of Chronic Kidney Disease in India is increasing at an alarming rate; at least 16% of the population suffers from CKD.
  • Approximately 1, 75,000 kidneys are needed for transplantation in India every year to save the lives of patients suffering from kidney failure. Just about 4,000 transplants are conducted annually.
  • The mean age of people with CKD was assessed and it was found that about 20% of patients aged 38 years.
  • In India, at least 30% of diabetics will develop chronic kidney disease because of diabetes.
  • 2,00,000 new patients need dialysis treatment every year in India
  • The majority of chronic kidney failure patients are diagnosed in the last stage; almost 50%first see nephrologists only in the last stage.
  • 6000 undergo kidney transplant, 60,000 undergo hemodialysis and 6000 prefer to take peritoneal dialysis in a year. Rest of around six-lakh people die for want of renal replacement therapy.


  • Shortage of Skilled Manpower for treatment of CKD.
  • Inaccessibility and high cost of the CKD Treatments.


  • Increase in the number of diabetes and hypertension diseases leads to increase in number of CKD.
  • Increasing aging population.


1. Coimbatore kidney hospital– Tamil Nadu

They have successfully performed over 18,000 haemodialysis and 200 kidney transplantation. Steroid Free Kidney Transplantation is the latest innovation from this hospital and it is helping to avoid steroid related complications in patients. They also perform stone removal, haemodialysis, Transurethral Resections of the Prostrate, etc.

2. Christian Medical College- Vellore

The nephrology department of Christian Medical College Vellore is specialized in kidney diseases. They have some of the finest doctors of India. Facilities offered here include hemodialysis, peritoneal dialysis, renal transplantation, diagnostic tests, biopsy, etc.

3. Indraprastha Apollo Hospital- Delhi

Located in Delhi established in 1996, this is where the first successful paediatric and adult liver transplants in India were performed. Apollo Delhi continues to remain the busiest solid organ transplant centre. The hospital has performed over 10,000 kidney transplants till date and performs about 400 every year.

4. Kokilaben Dhirubhai Ambani Hospital

Established in 2008, offers treatment for kidney related diseases and open to the wonders of the latest technology. There is a separate transplant ward that caters to such patients only and is assisted by nurses specially trained for this procedure. The hospital has a team of well-trained doctors and other medical professionals who are specialized in this field. They also undertake Hemodialysis as well as Peritoneal Dialysis for treating patients in severe condition.

5. Fortis hospital- Bangalore

It was established in 2006. This multi-specialty hospital offers advanced medical care in over 40 different specialties and is equipped with state of the art technology and is served by more than 150 experienced doctors. The hospital is JCI (Joint Commission International) and NABH (National Accreditation Board for Hospitals) accredited.


  • Diabetes and hypertension are the leading causes of CKD throughout the world
  • CKD care is expensive and imposes large micro- and macro-economic burden on individuals and countries.
  • The projected increase in the prevalence of diabetes, hypertension and CVD is likely to increase the CKD burden further.
  • Looking at the estimated figure of the growing CKD in the coming years, India holds a huge for Nephrology Healthcare.

Are you planning to build or restructure or venture in Nephrology Hospital in India? Looking for information about the major healthcare players in Government, Private diagnostic centres that are available in India? Are you looking to find out which part of the city’s is best to venture in or what all facilities are available and what all should be planned for new setup? In this article Hospaccx Healthcare Consultancy has mapped all on major players in terms of Nephrology facilities and healthcare scenario in India.

Below is the superficial and macro level survey if you need a refined market and financial feasibility or any other study related to healthcare is required you can contact Hospaccx Healthcare business consulting Pvt. ltd on [email protected] or [email protected] Or you can visit our website on


Please follow and like us: